Verified Treatment Center
Alchemy Addiction Recovery
Metairie, LA · 70001
Key Takeaways for Alchemy Addiction Recovery
- • Detox · IOP · MAT offered
- • Accepts Medicaid, Private insurance
- • SAMHSA-listed facility
- • Direct line available · Helpline free & confidential 24/7
About Alchemy Addiction Recovery
Alchemy Addiction Recovery is a SAMHSA-registered addiction-treatment facility located at Metairie, LA. The facility offers a continuum of care across multiple levels — Detox, IOP, MAT — which means it can, in principle, hold a patient across the arc of a typical treatment episode. Patient-level evaluation of this facility should distinguish three considerations: state licensure status, voluntary accreditation (CARF or Joint Commission), and clinical-framework alignment with current ASAM Criteria — each of which is independently verifiable.
Care levels at Alchemy Addiction Recovery
The facility offers a continuum of care across multiple levels — Detox, IOP, MAT — which means it can, in principle, hold a patient across the arc of a typical treatment episode. The practical question is whether it is genuinely strong at each level, or whether one level is the core business and the others are secondary. Operational prerequisite for admission: documented clinical assessment establishing medical necessity for the specific level of care Alchemy Addiction Recovery provides. The ASAM Criteria 4e framework is the benchmark standard for this assessment and is referenced in most major payer medical-necessity documents.
Insurance and payment
Payment and insurance posture: Alchemy Addiction Recovery accepts both Medicaid and commercial insurance, which is the broadest payer profile and typically correlates with programs that operate at scale across the economic spectrum. Pre-admission Verification of Benefits (VOB) documentation should include: specific plan product and network status, deductible status at time of admission, coinsurance rate applicable, prior authorization status and turnaround, and out-of-pocket accumulation. Under MHPAEA 2024 disclosure rules, plan-specific medical-necessity criteria must be available on request.
Specialty programming
The facility's documented specialty programming includes: Pregnant/postpartum women, Clients with co-occurring mental and substance use disorders, Clients with co-occurring pain and substance use disorders. Clinical verification of specialty programming should encompass credentialed staff profile, programming-hour documentation, and specialty-specific medical-necessity documentation for third-party authorization. The MHPAEA 2024 rule addresses specialty-program network adequacy for patients requiring specific clinical capabilities.
Before you call
Pre-admission due-diligence for Alchemy Addiction Recovery: (1) ASAM 4e level-of-care documentation matching clinical assessment; (2) written Verification of Benefits specific to insurance product; (3) MAT policy documentation (particularly buprenorphine and methadone continuation protocols for opioid use disorder patients); (4) accreditation verification via CARF or Joint Commission provider-search tools; (5) state licensing status confirmed via LA behavioral-health regulator inspection records. The facility's documented pharmacotherapy offerings suggest MAT is available — confirm the specific medications and prescriber access during the admissions conversation.
Listing sourced from the SAMHSA Behavioral Health Treatment Services Locator. Data last synced April 2026. Verify current programs directly with the facility.
Alchemy Addiction Recovery at a Glance
Levels of care
Detox · IOP · MAT
Service settings
Outpatient, Outpatient detoxification, Intensive outpatient treatment, Outpatient methadone/buprenorphine or naltrexone treatment, Regular outpatient treatment
Therapy approaches
Anger management, Brief intervention, Cognitive behavioral therapy, Motivational interviewing, Matrix Model, Relapse prevention
Age groups
Young Adults, Adults
Special populations
Pregnant/postpartum women, Clients with co-occurring mental and substance use disorders, Clients with co-occurring pain and substance use disorders
Medications
Acamprosate (Campral®), Disulfiram, Buprenorphine with naloxone, Buprenorphine (extended-release, injectable), Naltrexone (oral), Naltrexone (extended-release, injectable)
Insurance & Payment Accepted
Confirm in-network status before admission — verification is free.
Contact & Location
Address
4430 South I-10 Service Road West, Metairie, LA 70001
Facility direct line
504-941-7580Website
www.acercanhelp.com